Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Baranova, V. Voinov, O. Baklanova (Saint-Petersburg, Russian Federation). 30 years experience of plasmapheresis using in complex treatment of pulmonary sarcoidosis (PS). Eur Respir J 2014; 44: Suppl. 58, 4510

Member's Comments

No comment yet.

Related content which might interest you: ANCA associated vasculitis – Evaluation of diagnosis, treatment and outcome in a group of 68 patients Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Pulmonary embolism (PE) in patients with pulmonary sarcoidosis (PS) Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Exceptional extra pulmonary tuberculosis localizations: A 15 years series Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014 B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 The presentation and outcome of chronic pulmonary lobar collapse in children Source: International Congress 2014 – Neonatal and paediatric intensive care Year: 2014 Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014 The experience of use plasmaferesis in complex treatment in patients with pulmonary sarcoidosis (PS) Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008 Treatment of advanced homogenous emphysema with endobronchial coils compared to NETT subjects who received LVRS or medical therapy Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 Low cognitive ability in patients with bronchiectasis Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Efficacy and safety of modified anti-tubercular treatment(ATT) regimens in treatment of tuberculosis(TB) in patients with underlying chronic liver disease(CLD) Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Paradoxical response to bronchodilators: Radiologic correlates and clinical implications Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Is clinical presentation different between men and women with COPD? Source: International Congress 2014 – Clinical presentations Year: 2014 Patients’ adherence to chronic treatment of pulmonary diseases Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level Source: International Congress 2014 – COPD markers Year: 2014 Clinical caracteristics of pulmonary actinomycosis: 10 years‘ follow up Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 Pulmonary aspergilloma (about 76 cases) Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Sarcoidosis Source: Respipedia Article Year: 2017 Longitudinal performance of the bronchiectasis severity index (BSI) in patients on regular intravenous (IV) antibiotic therapy for bronchiectasis Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016